SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016443
Filing Date
2022-08-10
Accepted
2022-08-10 16:03:26
Documents
76
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q spro-20220630.htm   iXBRL 10-Q 3765178
2 EX-10.1 spro-ex10_1.htm EX-10.1 77232
3 EX-10.2 spro-ex10_2.htm EX-10.2 69170
4 EX-10.3 spro-ex10_3.htm EX-10.3 134777
5 EX-10.4 spro-ex10_4.htm EX-10.4 144962
6 EX-31.1 spro-ex31_1.htm EX-31.1 12680
7 EX-31.2 spro-ex31_2.htm EX-31.2 12709
8 EX-32 spro-ex32.htm EX-32 11495
9 GRAPHIC img174306186_0.jpg GRAPHIC 33177
10 GRAPHIC img175229707_0.jpg GRAPHIC 33177
  Complete submission text file 0000950170-22-016443.txt   12308069

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT spro-20220630_lab.xml EX-101.LAB 585689
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT spro-20220630_def.xml EX-101.DEF 307767
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT spro-20220630_pre.xml EX-101.PRE 464339
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT spro-20220630.xsd EX-101.SCH 84590
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT spro-20220630_cal.xml EX-101.CAL 46044
70 EXTRACTED XBRL INSTANCE DOCUMENT spro-20220630_htm.xml XML 2006127
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38266 | Film No.: 221151762
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences